🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

RecruitingNAAges 50 Years - anyAllLudwig-Maximilians - University of Munich
NCT06711952 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum * Provision of signed, written and dated informed consent * Capacity to give informed consent Exclusion Criteria: * dementia in a very advance stage * Illiteracy
💊

What it tests

  • Subjective Cognitive Decline-Questionnaire (SCD-Q)
  • Cognitive Failure Questionnaire (CFQ)
  • biomarkers
  • Cognitive Tests
📍

Where

1 site
Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
München, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy